Background: Type D personality is associated with poor cardiovascular outcome in patients with coronary or peripheral arterial disease. Whether Type D personality is associated with cardiovascular risk in persons without overt cardiovascular disease remains unknown. We hypothesized that Type D personality is associated with higher prevalence of traditional cardiovascular risk factors and higher concentration of C-reactive protein.
Introduction
The term Type D personality describes people with a stable tendency through time and situations to experience negative emotions and to inhibit the expression of these in social situations. 1 In patients with established coronary heart disease or peripheral vascular disease, the presence of Type D personality has been associated with increased risk of new coronary events or cardiac death, above and beyond the prognostic information provided by traditional risk factors. [2] [3] [4] The pathophysiological mechanisms responsible for the association between Type D personality and cardiovascular risk are not known. 5 The prevalence of somatic risk factors such as obesity, hypertension, hyperlipidaemia or diabetes have not been reported to be different between Type D and non-Type D patients with cardiovascular disease (CVD), but a few studies suggest that Type D patients are more prone to exhibit unhealthy behaviour. 6, 7 Type D personality characteristics will, by definition, be present before any cardiovascular event, but there are to our knowledge no studies on the implication of Type D personality on cardiac outcome and few studies on association with cardiovascular risk markers in persons without established CVD. 8 In a recent general-population based study, the presence of Type D was associated with physical inactivity, while a higher proportion of women with Type D reported hypertension and a higher proportion of men reported hypercholesterolaemia than non-Type D persons. 9 Furthermore, it has been hypothesized that systemic inflammation might be a common underlying biological substrate in both Type D personality and CVD. 5 Two studies have shown higher levels of pro-inflammatory cytokines in Type D patients with stable heart failure, 10, 11 but to our knowledge there is no report on any association between the most widely available inflammatory biomarker, C-reactive protein (CRP), and Type D personality.
We therefore tested the hypotheses that in a general population-based sample of participants without established CVD, participants with Type D personality have a higher prevalence of cardiovascular risk factors and higher concentration of CRP compared to non-Type D personality participants.
Methods

Design and participants
This study was a part of the cross-sectional, general population-based Akershus Sleep Apnea Project, designed to investigate cardiovascular, psychosomatic, neurological and otopharyngeal aspects of obstructive sleep apnoea. This population was considered to be well-suited for investigations of associations between psychological and biological characteristics as the prevalences of established cardiovascular risk factors are known to be high in patients with obstructive sleep apnoea. 12 Among the randomly drawn 29,258 Norwegians receiving the study invitation, a total of 16,302 participants (55.7%) completed the Berlin Questionnaire, a risk-stratifying instrument for sleep apnoea. 13 The questionnaire includes screening questions for snoring, daytime somnolence, obesity and hypertension. The clinical phase of the study was based on a sample of 1772 participants, drawn in predefined strata by Berlin Questionnaire-risk status (66% high risk), gender and age ( Figure 1 ). Patients with diabetes, previous myocardial infarction and a history of otitis media surgery were oversampled. A total of 202 were not reached by telephone, 585 declined participation and 28 were excluded because of pregnancy, use of continuous positive airway pressure, physical impairment or insufficient Norwegian language skills. The remaining 422 were not contacted as the predefined strata were fully saturated. Subsequently, 535 participants (46.7% of contacted) were included (54.5% men, mean age 48 years). For the analyses in the present study 72 participants with established CVD (myocardial infarction, coronary or peripheral revascularization or cerebral stroke) were excluded ( Figure 1 ).
Data collection
All clinical data were collected during an overnight stay at Akershus University Hospital Stensby.
Type D personality. The presence of Type D personality was evaluated with a Norwegian version of the DS-14. 14 Forward and backward translations were performed according to standard criteria. DS-14 consists of 14 items, scored 0-4, with seven items each on two subscales of negative affectivity and social inhibition, respectively. The sum scores on each subscale were calculated, and participants were regarded as positive for negative affectivity or social inhibition if above 10. To be categorized with Type D personality both subscales must be positive. There were 32 incomplete questionnaires; 22 of these were included after simple imputation when 2 or fewer items were missing on each subscale. The remaining 10 participants were excluded from the analyses ( Figure 1 ). The Cronbachs alpha's for both subscales were 0.87.
Cardiovascular risk factors. Self-reported data on current daily smoking and leisure-time physical activity were obtained from standardized questions from the Cohort of Norway. 15 Light (no sweating or heavy breathing) or vigorous (inducing sweat or heavy breathing) physical activity was measured on a 4-point scale (none, <1 hour/week, 1-2 hour/week, !3 hours/week). Height, weight and waist-width were measured, and body mass index (BMI; weight/height 2 ) was calculated. Blood pressure and heart rate were measured in the sitting position, and the mean of the last two of three measures was calculated. From morning fasting blood samples lipid levels and glucose were analysed with standard enzyme assays.
Each risk factor was dichotomized as present or absent based on recommendations for cardiovascular risk assessment from the European Society of Cardiology: 16 Hypertension: Blood pressure >140/90 or on any antihypertensive; Obesity: BMI > 25 kg/m 2 or waist >102 cm for men and 88 cm for women; Hyperlipidaemia: Total cholesterol >5.0 mmol/L or LDL-cholesterol >3.0 mmol/L or on lipid-lowering treatment; Diabetes: Plasma glucose >6.0 mmol/L or on antidiabetic treatment; Low physical activity: <3 hours light or vigorous leisure-time physical activity per week; Current smoking: Regular daily tobacco smoking. Finally, the total number of cardiovascular risk factors was calculated for each participant by simply adding present risk factors (range 0-6).
The apnoea-hypopnoea index was recorded by an overnight polysomnographic recording and scored using the Somnologica software (Flaga-Medcare).
C-reactive protein. Fasting morning serum samples
were initially stored at -20 C, within two weeks frozen at -80 C, and after complete data collection analysed with a highly sensitive latex immunoassay kit on a COBAS INTEGRA400 (Roche), with a lower detection limit of 0.1 mg/L.
Statistics
Normality plots were made to ascertain a normalized distribution of the continuous variables. In case of non-normality, natural logarithmic transformation was performed. Comparison of continuous data between Type D and non-Type D participants was performed by unpaired t-tests, while the Mann-Whitney U-test was used for dichotomized and nominal data. In order to test a mediation model, cardiovascular risk factors that could explain the association between Type D personality and inflammation were entered as mediating mechanisms in a multiple linear regression analyses with CRP levels as dependent variable. A two-sided P < 0.05 was considered statistically significant in all analyses.
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Results
A total of 108 participants (23.6%) were categorized as having Type D personality. The crude levels of the clinical variables for each category are shown in Table 1 . Type D participants had significantly higher BMI, heart rate and serum triglyceride levels and spent less time on physical activity.
Comparisons between Type D and non-Type D participants regarding the prevalences of each dichotomized cardiovascular risk factor are shown in Figure 2 . In addition to a significantly higher prevalence of smoking, Type D participants were less physically active than non-Type D participants. However, there was no difference between the groups regarding obesity, which reflects that the observed increase in BMI was mostly due to a skewed distribution of extreme obesity (BMI > 40) in Type D participants (6.5% vs. 1.2%, P ¼ 0.005). Consequently, the total number of cardiovascular risk factors was significantly higher in Type D than non-Type D participants (mean (standard deviation, SD) 3.4 (1.3) vs. 3.0 (1.2), P ¼ 0.004). Furthermore, there were 49 participants (10.9%) with 5 or 6 risk factors present, of whom 16 (32.7%) had Type D personality.
The mean (SD) concentration of CRP in the whole group was 2.5 (4.9) mg/L. The concentration of CRP was significantly higher in Type D than in non-Type D participants (Table 1) , and correlated significantly, albeit weakly, with Type D personality (r ¼ 0.094, P ¼ 0.047). Similar to that observed for BMI, low leisure-time physical activity and serum triglyceride levels correlated with both CRP and Type D personality. Accordingly, these variables were included in a multivariate analysis as possible mediators, and Type D personality was then no longer associated with CRP (beta 0.061, P ¼ 0.567).
Discussion
We report that in participants without established CVD, the presence of Type D personality is associated with a higher prevalence of cardiovascular risk factors and higher concentration of CRP. The elevated level of CRP could be mediated by the higher prevalence of established risk factors, such as elevated BMI.
The higher total number of cardiovascular risk factors in Type D participants in our study could largely be attributed to higher prevalence of behaviour-dependent risk factors such as smoking and low physical activity. There is no consistent trend in previous studies reporting smoking habits in Type D and non-Type D patients. In two general population-based studies and a cohort of patients with peripheral arterial disease there were no difference in smoking habits between the groups, 4,7,9 while our study supports the results from another cohort of patients with coronary heart disease. 3 Hausteiner et al. reported a higher prevalence of physical inactivity (<1 hour/week) among Type D persons, and in a sample of healthy young adults, Type D persons reported less time spent outdoors, but no more dissatisfaction with their level of exercise. 7, 9 In a cardiac rehabilitation cohort, the objective exercise capacity was no different in patients scoring high on DS-14. 6 Both smoking and low physical activity could be targets for effective preventive efforts in persons with Type D personality. In an earlier randomized study, Type D patients benefited more than non-Type D patients from a cardiac rehabilitation programme due to higher compliance, willingness to reduce smoking and increased physical activity when given concurrent stress management addressing psychological distress. 6 In accordance with most of the previous studies we found no differences between Type D and non-Type D participants regarding the prevalences of established hypertension, hyperlipidaemia, obesity or diabetes. 3, 9 However, the level of BMI and triglycerides were higher among Type D participants. Low physical activity may be a mediating mechanism for these unfavourable metabolic changes, but other behavioural or biological factors not evaluated in the present study, such as dietary patterns, adherence to health advices and metabolic hormones, may also relate Type D to metabolic changes and subsequently increased cardiovascular risk. Furthermore, although not included in traditional risk assessment, 16 elevated heart rate has been considered an independent risk factor for cardiovascular death in healthy persons and for adverse events in patients with coronary heart disease in recent studies. 17, 18 Possible hypothesis to explain the increased heart rate in the Type D participants involves chronic activation of the hypothalamo-pituitary-adrenal axis with increased level of catecholamines and a shift in the sympathicovagal balance towards sympathetic activation. Both mechanisms have been observed in small studies of Type D participants, however without consistent findings. 19 Our hypothesis of elevated CRP levels in Type D participants was confirmed by the crude analysis, but increased BMI, triglycerides and low leisure-time physical activity attenuated the association. The previous studies indicating increased inflammatory activity in Type D personality have included patients with chronic heart failure (left ventricular ejection fraction <30%), but these data were not adjusted for metabolic variables known to influence on systemic inflammation. 10, 11 Our results suggest that increased inflammation may be mediated by other risk factors associated with Type D, rather than being an independent pathophysiological feature of Type D personality in a primary prevention setting. Still, the increased cardiovascular risk identified by increased CRP concentration in a Type D patient needs to be addressed.
There are obvious limitations in our study that should be taken into account when interpreting the data. Any consideration of causal association is not possible due to the cross-sectional design. The population was selected according to risk of obstructive sleep apnoea rather than CVD, but the high prevalence of cardiovascular risk factors indicates that our population was in fact a group at high risk for CVD. Moreover, as no association between objective sleep indices and Type D personality was observed, we believe that the present results may be extrapolated to other groups of patients at high risk of CVD in Western countries.
Persons scoring high on personality traits such as social inhibition may be underrepresented in epidemiological studies based on self-reported data. Nevertheless, our estimate of the prevalence of Type D personality is similar to previous reports. 14 Another limitation is the lack of adjustment for clinical depression and anxiety, which are closely associated with Type D personality, and may explain some of the association with the cardiovascular risk factors.
In conclusion, among participants with no history of CVD, Type D personality was associated with elevated BMI, triglycerides, heart rate, low leisure-time physical activity and increased prevalence of smoking. The concentration of CRP was elevated, and the clustering of traditional risk factors may be the major contributor to elevated CRP and subsequently increased cardiovascular risk in Type D patients. Our results may provide a rationale for future prospective studies of Type D personality in a primary prevention setting. Aims of such studies should include identification of a potential highrisk group in whom a modified intervention strategy customized to personality type may be required to achieve behavioural modification and significant risk reduction. More data are clearly needed on possible biological correlates of Type D personality.
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